Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease.

Saved in:
Bibliographic Details
Title: Sodium-glucose cotransporter-2 inhibitors lower risk of kidney replacement therapy and mortality in bipolar disorder with chronic kidney disease.
Authors: Singh B; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA.; Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA., Gonzalez Suarez ML; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA., Baweja R; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA., Abulseoud OA; Department of Psychiatry and Psychology, Mayo Clinic Arizona, Phoenix, AZ, USA., Saunders EFH; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA., Frye MA; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA., Baweja R; Department of Psychiatry and Behavioral Health, Pennsylvania State College of Medicine, Hershey, PA, USA.
Source: Therapeutic advances in psychopharmacology [Ther Adv Psychopharmacol] 2026 Feb 20; Vol. 16, pp. 20451253261423437. Date of Electronic Publication: 2026 Feb 20 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101555693 Publication Model: eCollection Cited Medium: Print ISSN: 2045-1253 (Print) Linking ISSN: 20451253 NLM ISO Abbreviation: Ther Adv Psychopharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2045-1253
DOI:10.1177/20451253261423437